Answers are grounded in this paper and cite their sources.
The Multiple Sclerosis (MS) therapeutic scenario has radically changed in the last few years, due to new insights on disease pathogenesis and course. Although MS is considered a prototype of the ce...
No takes yet. Share an insight, caveat, or question.
Zanghì et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: